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A New Desmocollin, Desmocollin 3, Is Expressed in All Cell Layers of Squamous Epithelia 
King et a/ (p. 314) have identified a new human desmocollin, 
designated desmocollin 3 (DSC3), and have found that it is 
expressed in all living epithelial cells of various squamous epithelia. 
Desmocollins, along with desmogleins, are m embers of the cad-
berin superfamily of calcium-dependent cell adhesion molecules, 
which are the major glycoproteins of desmosomes, specialized 
adhesion structures found between cells in stratifi ed epithelia . The 
authors found three distinct isoforms of desmocollin in human 
foreskin epidermis; DSC1 and DSC2 had been previously identi-
fied, and now a third isoform, DSC3, has been discovered . Using 
rev erse transcriptase-polymerase chain reaction (RT-PCR), King et 
a/ cloned the entire coding sequence of the longer DSC3 splice 
variant. The authors found that DSC3 showed 67% homology with 
DSC2 and 52% homology with DSCl, and they localized it to 
chromosome 18, w here DSC3 appears to be closely associated with 
other desmosomal cadher:in genes. Using ifl. situ hybridization and 
immunofluorescence, King and colleagues compared expression of 
DSC3 with that of DSC2 and DSC1 and found that DSC3 was 
expressed with DSC2, in all living cell layers of the epidermis, 
including the basal cell layer, but that DSCl was expressed only in 
the uppet· spinous and granular cell layers, and never in the basal 
layer. When they examined nonkeratinizing stratified human epi-
thelia (buccal mucosa, cervix, and esophagus), they found that the 
expression ofDSC2 and DSC3 in these epithelia was the same as in 
the epidermis, but DSCl was not expressed at all. 
Mouse Melanocytes Require c-Kit for Postnatal Differentiation 
Okura and coll eagues (p. 322) report that melanocytes in newborn 
mice are c-Kit dependent and undergo apoptosis when receptors 
encoded by the c-Kit gene are blocked in the first few days after 
birth. Melanocytes are neural crest-derived cells that contain 
tyrosinase and synthesize melanin. c-Kit is a gene encoding a 
receptor with tyrosine kinase activity; the receptor h as been shown 
previously to act in a ligand-dependent manner, meaning that it is 
activated when the receptor is occupied, and promotes embryonic 
development of melanocytes. These authors used an antibody to 
c-Kit to block its function. This resulted in a dramatic reduction of 
coat color, indicating that melanocytes in hair follicles were affected 
by the antibody to the c-Kit protein, although the precise stage at 
which the antibody acted was n ot clear. To determine the exact 
stage at which melanocytes require c-Kit for further difFerentiation, 
the authors used the same antibody to inject C57 black mice at 
various times after birth and studied melanocytes in the follicles, 
epidermis, and dermis by light and electron microscopy with dopa 
reactions and immunohistochentistry. In untreated mice, epidermal 
melanocytes were dopa positive and also stained with c-Kit anti-
body at or soon after birth. In the antibody-treated mice, the earlier 
the mice received the antibody, the fewer melanocytes they had in 
both the epidermis and hair follicles, and the more apoptotic 
melanocytes were observed in the follicles and dennis. T hese re-
sults indicate that melanocytes are dependent on c-Kit and under-
go apoptosis when c-Kit function is blocked . In addition, during the 
c-Kit-dependent period, melanocytes differentiate from dopa neg-
ative to dopa positive and migrate from the epidermis to the hair 
follicles. 
Phospholipase C Is Involved in the Keratinocyte Response to Pemphigus Antibody 
Esaki et al (p. 329) report that phospholipase C (PLC) plays an 
important role in the transmembrane signaling that presumably 
leads to cell-cell detachment after pemphigus antibody binds to the 
cell surface of keratinocytes. Pemphigus vulgaris (PV) is character-
ized by autoantibodies to desmoglein 3, a desmosomal protein. It 
has been suggested that acantholysis in PV is related to secreted 
keratinocyte proteinase, such as plasminogen activator, but the 
mechanism for acantho lysis is not clear. Previously, the authors 
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re ported that incubation w ith pemphi gus antisera increased ke rati-
nocyte intracellular calcium and inositol trisphosphate, but pem-
phigoid antisera did not. In addi tion , pemphigus antisera did not 
inhibit formation of desmosom es in cultured keratinocytes, while 
pemphigoid antisera did , suggesting that there must be dilferences 
in the keratinocyte responses to these antisera. To de termine what 
these dilferences might be, the authors examined antibody-induced 
transmembrane sign alin g by keratinocytes in response to p emphi-
gus and pemphigoid sera . Because PLC is activated after binding of 
IgG in pemphigus antisera to keratinocytes, the authors studied the 
elfects of a specifi c inhibitor of PLC on the pemphigus antibody-
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induced changes in calcium concentration , inositol trisphosphate, 
plasminogen activator, and cell-cell attachment. They found that 
binding of the pemphigus antibody to the cell surface immediately 
in creased the calcium concentration and inositol trisphosphate 
content of the keratinocytes and that plasminogen activator was 
increased in the culture m edium 24 h later. In addition, pre-incubation 
with the PLC inhibitor dramatically reduced these increases and also 
inhibited cell-cell detachment. These results sugges t that PLC plays a 
critical role in cell-cell detaclm1ent after binding of pemphigus antisera 
to the keratinocyte cell surfuce. 
IL-1 Plays a Critical Role m Contact Hypersensitivity 
Kondo and colleagues (p. 334) report that interleukin-1 receptor 
antagonist (IL-1ra), a naturally occurring inhibitor ofinterleukin-1 
(IL-1) , elfectively i:nhibits both the sensitiza tion and the elicitation 
phases of contact h ypersensitivity. Contact hyp ersensitivity is a 
T -ce ll-mediated reaction that occurs after immunization or chal-
lenge with reactive baptens. Langerhans cell s, antigen-presenting 
de ndritic cells, are crucial to the developm en t of this reaction. IL-1 , 
in tum, is believed to be important in the response to exogenous 
stim uli and promotes infl ammation, resulting in swelling and 
accumulation of neutrophils. It can also upregulate syngeneic and 
allogeneic mixed lymphocyte reaction responses and has mitogenic 
elfects on dendriti c cells. To clarify the role IL-1 might play in 
contac t hypersensitivity, Kondo and co-worke rs used recombinant 
IL-1 receptor antagonist, which blocks IL-1 binding to its receptors 
but has no agonist activity. Local i•"tiection of IL-1ra into sensitized 
Balbi c mice just before challenge resulted in signifi cant reduction 
of contact hypersen sitivity as assessed by ear swelling . Inhibition 
occurred if the IL-1ra was administered in the 24-h period just 
be fore challenge, whereas no suppression was observed if IL-1ra 
was applied 48 h before challenge or at any time after challenge. 
Local administration to naive mice 5 h before sensitization also 
suppressed contact hypersensitivity. T he findings show that IL-lra 
is an effective inhibitor of both the sensitization and the elicitation 
phases of con tact hypersensitivity, indicating that IL-1 activity is 
required for optimal development the response . 
Do Sunscreens Protect Against UV-Induced Immunosuppression? 
In this issu e two groups examine tlus question . Roberts and Beasley 
(p. 339) report that commercially available sunscreen loti.ons 
prevent ultraviqlet (UV)-induced immunosuppressio n after an 
acute dose of ultraviolet radiatio n that simulates sunlight. For 
ch ronic UV designed to simulate daily low level exposure to the 
sun, Bestak el a/ (p. 345) report that sunscreens olfer som e, but 
minimal, iJnmunoprotection and that the best sunscreen s are the 
o nes with the broadest spectral absorbency. Although it has been 
shown that sunscreen s protect against sunburn , photoagin g, DNA 
damage, and UV carcinogenesis, it was not clear that they co uld 
prevent UV-induced immune dam age. UV-induced damage to the 
immune system can be detected by impaired generation oflocal and 
systemic con tact hypersensitivi ty reactions to haptens in both 
human s and rodents. Local immunosuppression results in a reduced 
contact hypersensitivity reaction when hapten is applied to the 
irradiated skin site, a phenomenon attributed to the depletion or 
functional inactivation of Langerhans cells. Systemic immunosup-
pression is shown by reduced contact hypersensitivity at a site 
distant from the site of irradiation. UV radiation can also induce 
specific tolerance when the sam e hap ten is applied to an unirradi-
ated site at a later date. Roberts and Beasley exposed C 3 H mice to 
a fixed UV dose that caused m aximal Langerhans cell depletion and 
suppression of the contact hypersensi tivity reac tion. T hey found 
that mice protected with sunscreens of SPF-1 5 and SPF-30 
mounted norma l contact hypersensitivity responses and that nuce 
protected w ith sunscreen s of SPF-4 and SPF-8 had signifi cantly 
greater responses than unprotected mice. They also showed that an 
SPF- 15 sunscreen' s immune protection valu e was 30 times the 
minimum immunosuppressive dose for solar simttlator UV, 7.5 
times tlus dose for Kodacel fi ltered sunlamps, and 2 tim es the dose 
for the unfiltered lamp. Thus, for an acute UV dose, commercial 
sunscreen lotions prevented solar sp ectrum UV-induced suppres-
sion at a level exceeding the labeled SPF. For chronic low-dose 
solar-simulated UV radiation, Bestak et a/ found dilferent results. 
They irradiated Balb/c and C 3 H /HeJ mice daily for 4 weeks \'l'ith 
suberyth emal doses of~UVB , w luch produced local, but not sys-
temic, immunosuppression, and compared the ability o f two UVB-
absorbing sunscreens [2-ethylhexyl p-methoxycinnamate acid (2-
EHMC) and Padimate 0) and two physical sunscreens (titanium 
dioxide and zinc oxide) to protect th e skin immune system. Both 
2-EHMC and titmuum w ere protective, whereas Padimate 0 was 
associated with more immunosuppression . When the accumulated 
dose was increased by only 12 .7%, however, a dose which caused 
systenuc immunosuppression , none of the sunscreens protected 
from immunosuppression, but 2-EHMC and titanium protected 
from toleran ce . These results suggest that different mechanisms 
may b e involved in UV-induced immunosuppression and tolerance. 
In addition, neither 2-EHMC nor Padimate 0 , which absorb 
predominantly UVB but not UV A, completely protected against 
UV-induced immunosuppression, suggesting that chronic exposure 
to longer wavelengths of UV m ay have deleterious effects on the 
skin immune system . The studies indicate that mixtures of sun-
screens m ay provide better immune protection than single agents. 
